Preliminary Results of Prophylactic Tocilizumab after Axicabtageneciloleucel (axi-cel; KTE-C19) Treatment for Patients with Refractory,Aggressive Non-Hodgkin Lymphoma (NHL)

Autor: Locke, Frederick L., Neelapu, Sattva S., Bartlett, Nancy L., Lekakis, Lazaros J. *, Jacobson, Caron A., Braunschweig, Ira, Oluwole, Olalekan O. *, Siddiqi, Tanya, Lin, Yi, Timmerman, John M, Reagan, Patrick M., Bot, Adrian *, Rossi, John M. *, Sherman, Marika *, Navale, Lynn *, Jiang, Yizhou *, Aycock, Jeff S. *, Elias, Meg *, Wiezorek, Jeffrey S. *, Go, William Y., Miklos, David B.
Zdroj: In Blood 8 December 2017 130 Supplement 1:1547-1547
Databáze: ScienceDirect